Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.
Sempa JB, Welte A, Busch MP, Hall J, Hampton D, Facente SN, Keating SM, Marson K, Parkin N, Pilcher CD, Murphy G, Grebe E; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). Sempa JB, et al. Among authors: grebe e. PLoS One. 2019 Jul 26;14(7):e0220345. doi: 10.1371/journal.pone.0220345. eCollection 2019. PLoS One. 2019. PMID: 31348809 Free PMC article.
Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence.
Keating SM, Kassanjee R, Lebedeva M, Facente SN, MacArthur JC, Grebe E, Murphy G, Welte A, Martin JN, Little S, Price MA, Kallas EG, Busch MP, Pilcher CD. Keating SM, et al. Among authors: grebe e. J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):581-588. doi: 10.1097/QAI.0000000000001146. J Acquir Immune Defic Syndr. 2016. PMID: 27509247 Free PMC article.
Moving towards a reliable HIV incidence test - current status, resources available, future directions and challenges ahead.
Murphy G, Pilcher CD, Keating SM, Kassanjee R, Facente SN, Welte A, Grebe E, Marson K, Busch MP, Dailey P, Parkin N, Osborn J, Ongarello S, Marsh K, Garcia-Calleja JM; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). Murphy G, et al. Among authors: grebe e. Epidemiol Infect. 2017 Apr;145(5):925-941. doi: 10.1017/S0950268816002910. Epub 2016 Dec 22. Epidemiol Infect. 2017. PMID: 28004622 Free PMC article. Review.
Computational analysis of antibody dynamics identifies recent HIV-1 infection.
Seaton KE, Vandergrift NA, Deal AW, Rountree W, Bainbridge J, Grebe E, Anderson DA, Sawant S, Shen X, Yates NL, Denny TN, Liao HX, Haynes BF, Robb ML, Parkin N, Santos BR, Garrett N, Price MA, Naniche D, Duerr AC; CEPHIA group; Keating S, Hampton D, Facente S, Marson K, Welte A, Pilcher CD, Cohen MS, Tomaras GD. Seaton KE, et al. Among authors: grebe e. JCI Insight. 2017 Dec 21;2(24):e94355. doi: 10.1172/jci.insight.94355. JCI Insight. 2017. PMID: 29263306 Free PMC article.
Development of antibody biomarkers of long term and recent dengue virus infections.
Nascimento EJM, Huleatt JW, Cordeiro MT, Castanha PMS, George JK, Grebe E, Welte A, Brown M, Burke DS, Marques ETA. Nascimento EJM, et al. Among authors: grebe e. J Virol Methods. 2018 Jul;257:62-68. doi: 10.1016/j.jviromet.2018.04.009. Epub 2018 Apr 21. J Virol Methods. 2018. PMID: 29684416 Free article.
Population-level HIV incidence estimates using a combination of synthetic cohort and recency biomarker approaches in KwaZulu-Natal, South Africa.
Grebe E, Welte A, Johnson LF, van Cutsem G, Puren A, Ellman T, Etard JF; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA); Huerga H. Grebe E, et al. PLoS One. 2018 Sep 13;13(9):e0203638. doi: 10.1371/journal.pone.0203638. eCollection 2018. PLoS One. 2018. PMID: 30212513 Free PMC article.
70 results